1 February 2007   
 

CLSI 2007 Leadership Conference
18-20 April 2007
Event and registration info

News
Executive Vice President's Message
Antibiotic susceptibility testing matters
Announcement: New 2007 CLSI Catalog
Press Releases
Standards Status
Vote and Deadlines
Recently Approved Documents
Events and Exhibits
Upcoming Events
Upcoming Presentations
CLSI Meetings Calendar
Participate in CLSI
Volunteer
New and Sustaining Members
Update Your Subscription
 
CLSI Home Page
Search Past Issues
Update Your Contact Information
Print this article Print all articles
 
 
 
Winner of the Silver Award for Patient Education in the WWW Health Awards Program
 
Standards Status
Vote and Deadlines

User Protocol for Evaluation of Qualitative Test Performance (EP12-A2)

CLSI submits the following for vote as a candidate-for-advancement consensus document.  The document and ballot is available to delegates and alternates of Active and Associate Active member organizations through CLSI Forums.  

EP12-A2User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline—Second Edition This document provides a consistent approach for protocol design and data analysis when evaluating qualitative diagnostic tests. Guidance is provided for both precision and method-comparison studies. The deadline for the completed ballot for EP12-A2 to be received at the CLSI offices is 2 April 2007.


Under our Administrative Procedures, a CLSI document approved by the area committee at the first level of the consensus process is submitted to delegates as a “candidate-for-advancement” consensus document. This begins the voting and approval period by the delegates.

As a delegate, your vote is to affirm (or reject) the document for advancement as a CLSI document. Please send your completed ballot to the CLSI offices by the above deadline.

In the consensus process, comments are invited at each publication stage. In each edition, the responsible committee includes a summary of comments on the prior edition and its responses to them. Any comments received on a candidate-for-advancement consensus document as a result of delegate voting and consensus review will be addressed by the committee during the document’s advancement.

Find out more about Active and Associate Active membership. [ return to top ]

For more information or to contact us directly, please visit www.clsi.org
©2007 Clinical and Laboratory Standards Institute